MDT
Medtronic plc
Price Chart
Latest Quote
$82.03
+0.10 (+0.13%)
Current Price
| Previous Close | $81.93 |
| Open | $82.10 |
| Day High | $82.68 |
| Day Low | $81.48 |
| Volume | 4,488,753 |
Stock Information
| Quarterly Dividend / Yield | $2.88 / 3.52% |
| Shares Outstanding | 1.28B |
| Quarterly Dividend Yield | 3.52% |
| Quarterly Dividend | $2.88 |
| Total Debt | $28.07B |
| Cash Equivalents | $8.38B |
| Revenue | $36.36B |
| Net Income | $4.80B |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $104.85B |
| P/E Ratio | 21.90 |
| EPS (TTM) | $3.73 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $125.09B |
| Sales | $36.36B |
| Income | $4.80B |
| Book/sh | $38.17 |
| Cash/sh | $6.53 |
| Employees | 95K |
Financial Ratios
| Debt/Eq | 57.06 |
| EPS Growth TTM | 17.70% |
Returns & Margins
| ROE | 9.93% |
| Gross Margin | 65.38% |
| Operating Margin | 21.30% |
| Profit Margin | 13.20% |
Ownership
| Insider Ownership | 0.31% |
| Institutional Ownership | 89.39% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 12.67 |
| PEG | 1.29 |
| P/S | 2.88 |
| P/B | 2.14 |
Analyst Data
| Recommendation | buy |
| Target Price | $103.15 |
Technical Indicators
| SMA20 | $76.99 |
| SMA50 | $81.29 |
| SMA200 | $91.47 |
| RSI | 66.29 |
| ATR | 1.9607 |
| Shares Float | 1.28B |
| Short Float | 1.14% |
| Short Ratio | 1.50 |
| Volatility | 0.60 |
| Rel Volume | 1.25 |
Performance History
| Week | +10.65% |
| Month | +5.24% |
| Quarter | -9.42% |
| 6 Months | -18.66% |
| YTD | -14.28% |
| Year | -1.56% |
| 3 Years | +8.78% |
| 5 Years | -24.84% |
| 10 Years | +26.75% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $81.67 | 15,280,947 |
| 2026-06-04 | $81.93 | 19,849,600 |
| 2026-06-03 | $77.95 | 20,289,700 |
| 2026-06-02 | $73.75 | 14,441,700 |
| 2026-06-01 | $73.98 | 14,209,800 |
| 2026-05-29 | $73.81 | 22,243,500 |
| 2026-05-28 | $75.57 | 13,097,900 |
| 2026-05-27 | $75.98 | 10,474,000 |
| 2026-05-26 | $77.60 | 6,703,900 |
| 2026-05-22 | $78.60 | 7,051,500 |
| 2026-05-21 | $78.15 | 9,226,500 |
| 2026-05-20 | $78.15 | 9,665,700 |
| 2026-05-19 | $78.58 | 11,931,700 |
| 2026-05-18 | $77.32 | 10,973,300 |
| 2026-05-15 | $76.15 | 9,127,300 |
| 2026-05-14 | $76.97 | 7,444,000 |
| 2026-05-13 | $76.21 | 10,975,200 |
| 2026-05-12 | $76.82 | 10,255,200 |
| 2026-05-11 | $74.54 | 10,495,700 |
| 2026-05-08 | $76.15 | 10,199,500 |
| 2026-05-07 | $77.96 | 10,008,300 |
| 2026-05-06 | $77.60 | 11,477,400 |
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
đ° Latest News
J&J, Medtronic back CereVascâs $85M funding round
MedTech Dive âĸ 2026-06-05T16:48:00Z
Is Medtronic (MDT) a Buy as Wall Street Analysts Look Optimistic?
Zacks âĸ 2026-06-05T13:30:03Z
3 High-Yielding Dividend Stocks That Just Raised Their Payouts
Motley Fool âĸ 2026-06-05T12:20:00Z
How To Earn $500 A Month From Medtronic Stock After Q4 Earnings
Benzinga âĸ 2026-06-05T02:31:04Z
Stocks Rebound on Strength in Banks and Managed Healthcare
Barchart âĸ 2026-06-04T20:32:37Z
Medtronic Bottoms, Healthy Rebound Ahead
MarketBeat âĸ 2026-06-04T17:10:00Z
Stocks Mixed as Tech Weakness Weighs
Barchart âĸ 2026-06-04T15:16:14Z
CereVasc raises $85m to advance hydrocephalus treatment
Medical Device Network âĸ 2026-06-04T14:49:13Z
Medtronic Balances Hugo Robotics Expansion With Ongoing Cardiovascular Device Recalls
Simply Wall St. âĸ 2026-06-04T14:15:03Z
Company News for Jun 4, 2026
Zacks âĸ 2026-06-04T13:29:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $10,578,000,000 | $10,262,000,000 | $9,720,000,000 | $9,171,000,000 |
| Cost Of Revenue | $11,632,000,000 | $11,216,000,000 | $10,719,000,000 | $10,145,000,000 |
| Total Revenue | $33,537,000,000 | $32,364,000,000 | $31,227,000,000 | $31,686,000,000 |
| Operating Revenue | $33,537,000,000 | $32,364,000,000 | $31,227,000,000 | $31,686,000,000 |
| Expenses | ||||
| Interest Expense | $729,000,000 | $719,000,000 | $636,000,000 | $553,000,000 |
| Total Expenses | $26,997,000,000 | $26,844,000,000 | $25,397,000,000 | $25,778,000,000 |
| Other Income Expense | $-182,000,000 | $37,000,000 | $170,000,000 | $163,000,000 |
| Other Non Operating Income Expenses | $402,000,000 | $412,000,000 | $515,000,000 | $318,000,000 |
| Net Non Operating Interest Income Expense | $-729,000,000 | $-719,000,000 | $-636,000,000 | $-553,000,000 |
| Interest Expense Non Operating | $729,000,000 | $719,000,000 | $636,000,000 | $553,000,000 |
| Operating Expense | $15,365,000,000 | $15,628,000,000 | $14,678,000,000 | $15,633,000,000 |
| Other Operating Expenses | $-23,000,000 | $464,000,000 | $-131,000,000 | $862,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $4,662,000,000 | $3,676,000,000 | $3,758,000,000 | $5,039,000,000 |
| Net Interest Income | $-729,000,000 | $-719,000,000 | $-636,000,000 | $-553,000,000 |
| Normalized Income | $5,149,056,000 | $3,963,250,000 | $4,001,225,000 | $5,181,135,000 |
| Net Income From Continuing And Discontinued Operation | $4,662,000,000 | $3,676,000,000 | $3,758,000,000 | $5,039,000,000 |
| Total Operating Income As Reported | $5,955,000,000 | $5,144,000,000 | $5,485,000,000 | $5,752,000,000 |
| Net Income Common Stockholders | $4,662,000,000 | $3,676,000,000 | $3,758,000,000 | $5,039,000,000 |
| Net Income | $4,662,000,000 | $3,676,000,000 | $3,758,000,000 | $5,039,000,000 |
| Net Income Including Noncontrolling Interests | $4,691,000,000 | $3,705,000,000 | $3,784,000,000 | $5,062,000,000 |
| Net Income Continuous Operations | $4,691,000,000 | $3,705,000,000 | $3,784,000,000 | $5,062,000,000 |
| Pretax Income | $5,628,000,000 | $4,837,000,000 | $5,364,000,000 | $5,517,000,000 |
| Special Income Charges | $-584,000,000 | $-375,000,000 | $-345,000,000 | $-155,000,000 |
| Operating Income | $6,540,000,000 | $5,520,000,000 | $5,830,000,000 | $5,908,000,000 |
| Depreciation Amortization Depletion Income Statement | $1,807,000,000 | $1,693,000,000 | $1,698,000,000 | $1,733,000,000 |
| Depreciation And Amortization In Income Statement | $1,807,000,000 | $1,693,000,000 | $1,698,000,000 | $1,733,000,000 |
| Amortization Of Intangibles Income Statement | $1,807,000,000 | $1,693,000,000 | $1,698,000,000 | $1,733,000,000 |
| Gross Profit | $21,905,000,000 | $21,148,000,000 | $20,508,000,000 | $21,541,000,000 |
| Per Share | ||||
| Diluted EPS | $3.61 | $2.76 | $2.82 | $3.73 |
| Basic EPS | $3.63 | $2.77 | $2.83 | $3.75 |
| Other | ||||
| Tax Effect Of Unusual Items | $-96,944,000 | $-87,750,000 | $-101,775,000 | $-12,865,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $9,802,000,000 | $8,578,000,000 | $9,042,000,000 | $8,932,000,000 |
| Total Unusual Items | $-584,000,000 | $-375,000,000 | $-345,000,000 | $-155,000,000 |
| Total Unusual Items Excluding Goodwill | $-584,000,000 | $-375,000,000 | $-345,000,000 | $-155,000,000 |
| Reconciled Depreciation | $2,861,000,000 | $2,647,000,000 | $2,697,000,000 | $2,707,000,000 |
| EBITDA (Bullshit earnings) | $9,218,000,000 | $8,203,000,000 | $8,697,000,000 | $8,777,000,000 |
| EBIT | $6,357,000,000 | $5,556,000,000 | $6,000,000,000 | $6,070,000,000 |
| Diluted Average Shares | $1,289,900,000 | $1,330,200,000 | $1,332,800,000 | $1,351,400,000 |
| Basic Average Shares | $1,285,600,000 | $1,327,700,000 | $1,329,800,000 | $1,342,400,000 |
| Diluted NI Availto Com Stockholders | $4,662,000,000 | $3,676,000,000 | $3,758,000,000 | $5,039,000,000 |
| Minority Interests | $-29,000,000 | $-28,000,000 | $-26,000,000 | $-22,000,000 |
| Tax Provision | $936,000,000 | $1,133,000,000 | $1,580,000,000 | $456,000,000 |
| Other Special Charges | $317,000,000 | $149,000,000 | $-30,000,000 | $95,000,000 |
| Restructuring And Mergern Acquisition | $267,000,000 | $226,000,000 | $375,000,000 | $60,000,000 |
| Amortization | $1,807,000,000 | $1,693,000,000 | $1,698,000,000 | $1,733,000,000 |
| Research And Development | $2,732,000,000 | $2,735,000,000 | $2,696,000,000 | $2,746,000,000 |
| Selling General And Administration | $10,849,000,000 | $10,736,000,000 | $10,415,000,000 | $10,292,000,000 |
Fetched: 2026-06-04
Balance Sheet (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-5,380,000,000 | $-3,997,000,000 | $-4,786,000,000 | $-3,545,000,000 |
| Total Assets | $91,680,000,000 | $89,981,000,000 | $90,948,000,000 | $90,981,000,000 |
| Total Non Current Assets | $67,865,000,000 | $68,046,000,000 | $69,274,000,000 | $67,920,000,000 |
| Other Non Current Assets | $3,584,000,000 | $4,047,000,000 | $3,959,000,000 | $3,008,000,000 |
| Non Current Accounts Receivable | $4,040,000,000 | $3,657,000,000 | $3,477,000,000 | $3,403,000,000 |
| Goodwill And Other Intangible Assets | $53,404,000,000 | $54,211,000,000 | $56,269,000,000 | $56,096,000,000 |
| Other Intangible Assets | $11,667,000,000 | $13,225,000,000 | $14,844,000,000 | $15,594,000,000 |
| Current Assets | $23,814,000,000 | $21,935,000,000 | $21,675,000,000 | $23,059,000,000 |
| Other Current Assets | $2,858,000,000 | $2,585,000,000 | $2,425,000,000 | $2,319,000,000 |
| Inventory | $5,476,000,000 | $5,217,000,000 | $5,293,000,000 | $4,616,000,000 |
| Receivables | $6,515,000,000 | $6,128,000,000 | $5,998,000,000 | $5,551,000,000 |
| Accounts Receivable | $6,515,000,000 | $6,128,000,000 | $5,998,000,000 | $5,551,000,000 |
| Allowance For Doubtful Accounts Receivable | $-199,000,000 | $-173,000,000 | $-176,000,000 | $-230,000,000 |
| Gross Accounts Receivable | $6,714,000,000 | $6,301,000,000 | $6,174,000,000 | $5,781,000,000 |
| Cash Cash Equivalents And Short Term Investments | $8,965,000,000 | $8,005,000,000 | $7,959,000,000 | $10,573,000,000 |
| Cash And Cash Equivalents | $2,218,000,000 | $1,284,000,000 | $1,543,000,000 | $3,714,000,000 |
| Debt | ||||
| Net Debt | $26,240,000,000 | $23,679,000,000 | $22,757,000,000 | $20,338,000,000 |
| Total Debt | $28,516,000,000 | $25,024,000,000 | $24,364,000,000 | $24,114,000,000 |
| Long Term Debt And Capital Lease Obligation | $25,642,000,000 | $23,932,000,000 | $24,344,000,000 | $20,372,000,000 |
| Long Term Debt | $25,590,000,000 | $23,877,000,000 | $24,287,000,000 | $20,316,000,000 |
| Current Debt And Capital Lease Obligation | $2,874,000,000 | $1,092,000,000 | $20,000,000 | $3,742,000,000 |
| Current Debt | $2,868,000,000 | $1,086,000,000 | $13,000,000 | $3,736,000,000 |
| Other Current Borrowings | $2,855,000,000 | - | $13,000,000 | $3,724,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $43,424,000,000 | $39,561,000,000 | $39,283,000,000 | $38,259,000,000 |
| Total Non Current Liabilities Net Minority Interest | $30,545,000,000 | $28,772,000,000 | $30,232,000,000 | $25,865,000,000 |
| Other Non Current Liabilities | $1,768,000,000 | $1,365,000,000 | $1,727,000,000 | $1,409,000,000 |
| Tradeand Other Payables Non Current | $1,574,000,000 | $1,859,000,000 | $2,360,000,000 | $2,087,000,000 |
| Non Current Deferred Liabilities | $403,000,000 | $515,000,000 | $708,000,000 | $884,000,000 |
| Non Current Deferred Taxes Liabilities | $403,000,000 | $515,000,000 | $708,000,000 | $884,000,000 |
| Current Liabilities | $12,879,000,000 | $10,789,000,000 | $9,051,000,000 | $12,394,000,000 |
| Other Current Liabilities | $1,000,000 | - | $-1,000,000 | - |
| Payables And Accrued Expenses | $7,490,000,000 | $7,322,000,000 | $7,083,000,000 | $6,531,000,000 |
| Payables | $3,807,000,000 | $3,740,000,000 | $3,502,000,000 | $2,980,000,000 |
| Total Tax Payable | $1,358,000,000 | $1,330,000,000 | $840,000,000 | $704,000,000 |
| Income Tax Payable | $1,358,000,000 | $1,330,000,000 | $840,000,000 | $704,000,000 |
| Accounts Payable | $2,449,000,000 | $2,410,000,000 | $2,662,000,000 | $2,276,000,000 |
| Equity | ||||
| Common Stock Equity | $48,024,000,000 | $50,214,000,000 | $51,483,000,000 | $52,551,000,000 |
| Total Equity Gross Minority Interest | $48,256,000,000 | $50,420,000,000 | $51,665,000,000 | $52,722,000,000 |
| Stockholders Equity | $48,024,000,000 | $50,214,000,000 | $51,483,000,000 | $52,551,000,000 |
| Other Equity Interest | $-1,000,000 | - | - | - |
| Gains Losses Not Affecting Retained Earnings | $-4,284,000,000 | $-3,318,000,000 | $-3,499,000,000 | $-2,265,000,000 |
| Other Equity Adjustments | $-4,284,000,000 | $-3,318,000,000 | $-3,499,000,000 | $-2,265,000,000 |
| Retained Earnings | $31,476,000,000 | $30,403,000,000 | $30,392,000,000 | $30,250,000,000 |
| Other | ||||
| Ordinary Shares Number | $1,281,934,628 | $1,311,337,531 | $1,330,809,036 | $1,330,743,395 |
| Share Issued | $1,281,934,628 | $1,311,337,531 | $1,330,809,036 | $1,330,743,395 |
| Tangible Book Value | $-5,380,000,000 | $-3,997,000,000 | $-4,786,000,000 | $-3,545,000,000 |
| Invested Capital | $76,482,000,000 | $75,177,000,000 | $75,783,000,000 | $76,603,000,000 |
| Working Capital | $10,935,000,000 | $11,146,000,000 | $12,624,000,000 | $10,665,000,000 |
| Capital Lease Obligations | $58,000,000 | $61,000,000 | $64,000,000 | $62,000,000 |
| Total Capitalization | $73,614,000,000 | $74,091,000,000 | $75,770,000,000 | $72,867,000,000 |
| Minority Interest | $232,000,000 | $206,000,000 | $182,000,000 | $171,000,000 |
| Additional Paid In Capital | $20,833,000,000 | $23,129,000,000 | $24,590,000,000 | $24,566,000,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Employee Benefits | $1,158,000,000 | $1,101,000,000 | $1,093,000,000 | $1,113,000,000 |
| Long Term Capital Lease Obligation | $52,000,000 | $55,000,000 | $57,000,000 | $56,000,000 |
| Current Capital Lease Obligation | $6,000,000 | $6,000,000 | $7,000,000 | $6,000,000 |
| Line Of Credit | $13,000,000 | $13,000,000 | $13,000,000 | $12,000,000 |
| Commercial Paper | $0 | $1,073,000,000 | $0 | - |
| Pensionand Other Post Retirement Benefit Plans Current | $2,514,000,000 | $2,375,000,000 | $1,949,000,000 | $2,121,000,000 |
| Current Accrued Expenses | $3,683,000,000 | $3,582,000,000 | $3,581,000,000 | $3,551,000,000 |
| Goodwill | $41,737,000,000 | $40,986,000,000 | $41,425,000,000 | $40,502,000,000 |
| Net PPE | $6,837,000,000 | $6,131,000,000 | $5,569,000,000 | $5,413,000,000 |
| Accumulated Depreciation | $-8,799,000,000 | $-7,922,000,000 | $-8,493,000,000 | $-7,952,000,000 |
| Gross PPE | $15,636,000,000 | $14,053,000,000 | $14,062,000,000 | $13,365,000,000 |
| Construction In Progress | $2,340,000,000 | $2,119,000,000 | $1,754,000,000 | $1,737,000,000 |
| Other Properties | $7,156,000,000 | $6,396,000,000 | $6,707,000,000 | $6,490,000,000 |
| Machinery Furniture Equipment | $3,295,000,000 | $2,872,000,000 | $2,952,000,000 | $2,617,000,000 |
| Buildings And Improvements | $2,685,000,000 | $2,506,000,000 | $2,487,000,000 | $2,351,000,000 |
| Land And Improvements | $160,000,000 | $159,000,000 | $162,000,000 | $170,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $3,779,000,000 | $3,668,000,000 | $3,440,000,000 | $3,070,000,000 |
| Work In Process | $744,000,000 | $642,000,000 | $789,000,000 | $682,000,000 |
| Raw Materials | $953,000,000 | $907,000,000 | $1,063,000,000 | $864,000,000 |
| Other Short Term Investments | $6,747,000,000 | $6,721,000,000 | $6,416,000,000 | $6,859,000,000 |
| Other Inventories | - | - | $1,000,000 | - |
Fetched: 2026-06-04
Cash Flow Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $5,185,000,000 | $5,200,000,000 | $4,580,000,000 | $5,978,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $7,044,000,000 | $6,787,000,000 | $6,039,000,000 | $7,346,000,000 |
| Cash Flow From Continuing Operating Activities | $7,044,000,000 | $6,787,000,000 | $6,039,000,000 | $7,346,000,000 |
| Operating Gains Losses | - | - | $53,000,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-1,859,000,000 | $-1,587,000,000 | $-1,459,000,000 | $-1,368,000,000 |
| Investing Cash Flow | $-1,937,000,000 | $-2,366,000,000 | $-3,493,000,000 | $-1,659,000,000 |
| Cash Flow From Continuing Investing Activities | $-1,937,000,000 | $-2,366,000,000 | $-3,493,000,000 | $-1,659,000,000 |
| Net Other Investing Changes | $-249,000,000 | $-261,000,000 | $4,000,000 | $-10,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-3,235,000,000 | $-2,138,000,000 | $-645,000,000 | $-2,544,000,000 |
| Issuance Of Capital Stock | $508,000,000 | $284,000,000 | $308,000,000 | $429,000,000 |
| Financing Cash Flow | $-4,361,000,000 | $-4,450,000,000 | $-4,960,000,000 | $-5,336,000,000 |
| Cash Flow From Continuing Financing Activities | $-4,361,000,000 | $-4,450,000,000 | $-4,960,000,000 | $-5,336,000,000 |
| Net Other Financing Charges | $-184,000,000 | $-3,000,000 | $-409,000,000 | $163,000,000 |
| Cash Dividends Paid | $-3,589,000,000 | $-3,666,000,000 | $-3,616,000,000 | $-3,383,000,000 |
| Common Stock Dividend Paid | $-3,589,000,000 | $-3,666,000,000 | $-3,616,000,000 | $-3,383,000,000 |
| Net Common Stock Issuance | $-2,727,000,000 | $-1,854,000,000 | $-337,000,000 | $-2,115,000,000 |
| Common Stock Issuance | $508,000,000 | $284,000,000 | $308,000,000 | $429,000,000 |
| Other | ||||
| Repayment Of Debt | $-1,070,000,000 | $0 | $-8,291,000,000 | $-1,000,000 |
| Issuance Of Debt | $3,209,000,000 | $1,073,000,000 | $7,693,000,000 | $0 |
| Interest Paid Supplemental Data | $762,000,000 | $826,000,000 | $606,000,000 | $540,000,000 |
| Income Tax Paid Supplemental Data | $1,819,000,000 | $1,622,000,000 | $1,548,000,000 | $996,000,000 |
| End Cash Position | $2,218,000,000 | $1,284,000,000 | $1,543,000,000 | $3,714,000,000 |
| Beginning Cash Position | $1,284,000,000 | $1,543,000,000 | $3,714,000,000 | $3,593,000,000 |
| Effect Of Exchange Rate Changes | $188,000,000 | $-230,000,000 | $243,000,000 | $-231,000,000 |
| Changes In Cash | $746,000,000 | $-29,000,000 | $-2,414,000,000 | $352,000,000 |
| Common Stock Payments | $-3,235,000,000 | $-2,138,000,000 | $-645,000,000 | $-2,544,000,000 |
| Net Issuance Payments Of Debt | $2,139,000,000 | $1,073,000,000 | $-598,000,000 | $-1,000,000 |
| Net Short Term Debt Issuance | $-1,070,000,000 | $1,073,000,000 | $5,000,000 | $0 |
| Short Term Debt Payments | $-1,070,000,000 | $0 | $-2,279,000,000 | $0 |
| Short Term Debt Issuance | $0 | $1,073,000,000 | $2,284,000,000 | $0 |
| Net Long Term Debt Issuance | $3,209,000,000 | $0 | $-603,000,000 | $-1,000,000 |
| Long Term Debt Payments | $0 | $0 | $-6,012,000,000 | $-1,000,000 |
| Long Term Debt Issuance | $3,209,000,000 | $0 | $5,409,000,000 | $0 |
| Net Investment Purchase And Sale | $269,000,000 | $-307,000,000 | $-171,000,000 | $-190,000,000 |
| Sale Of Investment | $8,495,000,000 | $7,441,000,000 | $7,343,000,000 | $9,692,000,000 |
| Purchase Of Investment | $-8,226,000,000 | $-7,748,000,000 | $-7,514,000,000 | $-9,882,000,000 |
| Net Business Purchase And Sale | $-98,000,000 | $-211,000,000 | $-1,867,000,000 | $-91,000,000 |
| Purchase Of Business | $-98,000,000 | $-211,000,000 | $-1,867,000,000 | $-91,000,000 |
| Net PPE Purchase And Sale | $-1,859,000,000 | $-1,587,000,000 | $-1,459,000,000 | $-1,368,000,000 |
| Purchase Of PPE | $-1,859,000,000 | $-1,587,000,000 | $-1,459,000,000 | $-1,368,000,000 |
| Change In Working Capital | $-1,054,000,000 | $-484,000,000 | $-967,000,000 | $-889,000,000 |
| Change In Other Working Capital | $-538,000,000 | $-345,000,000 | $-148,000,000 | $-65,000,000 |
| Change In Payables And Accrued Expense | $209,000,000 | $391,000,000 | $696,000,000 | $213,000,000 |
| Change In Inventory | $-292,000,000 | $-139,000,000 | $-939,000,000 | $-560,000,000 |
| Change In Receivables | $-433,000,000 | $-391,000,000 | $-576,000,000 | $-477,000,000 |
| Changes In Account Receivables | $-433,000,000 | $-391,000,000 | $-576,000,000 | $-477,000,000 |
| Other Non Cash Items | $310,000,000 | $573,000,000 | $270,000,000 | $138,000,000 |
| Stock Based Compensation | $429,000,000 | $393,000,000 | $355,000,000 | $359,000,000 |
| Provisionand Write Offof Assets | $123,000,000 | $90,000,000 | $73,000,000 | $58,000,000 |
| Asset Impairment Charge | $0 | $371,000,000 | $0 | $515,000,000 |
| Deferred Tax | $-316,000,000 | $-508,000,000 | $-226,000,000 | $-604,000,000 |
| Deferred Income Tax | $-316,000,000 | $-508,000,000 | $-226,000,000 | $-604,000,000 |
| Depreciation Amortization Depletion | $2,861,000,000 | $2,647,000,000 | $2,697,000,000 | $2,707,000,000 |
| Depreciation And Amortization | $2,861,000,000 | $2,647,000,000 | $2,697,000,000 | $2,707,000,000 |
| Amortization Cash Flow | $1,807,000,000 | $1,693,000,000 | $1,698,000,000 | $1,733,000,000 |
| Amortization Of Intangibles | $1,807,000,000 | $1,693,000,000 | $1,698,000,000 | $1,733,000,000 |
| Depreciation | $1,054,000,000 | $954,000,000 | $999,000,000 | $974,000,000 |
| Net Income From Continuing Operations | $4,691,000,000 | $3,705,000,000 | $3,784,000,000 | $5,062,000,000 |
Fetched: 2026-06-04